Nanomaterials for Drug Delivery
A special issue of Materials (ISSN 1996-1944). This special issue belongs to the section "Biomaterials".
Deadline for manuscript submissions: closed (21 February 2021) | Viewed by 41986
Special Issue Editors
Interests: nanomaterials; polymer nanocomposites; 2D and 3D materials; biopolymers; drug delivery; organic/inorganic hybrids; sol–gel chemistry; polymers synthesis; 3D bioprinting
Special Issues, Collections and Topics in MDPI journals
2. Lasers Department, National Institute for Laser, Plasma and Radiation Physics, RO-077125 Magurele, Romania
Interests: materials science and engineering; (micro-/nano-)biomaterials; biomedical devices; laser processing of (bio)materials; bioactive coatings; applied chemistry and chemical engineering; therapeutic (micro-/nano-)biomaterials; biomedicine and life sciences
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The interdisciplinary and multidisciplinary knowledge from modern nanobiotechnologies has contributed to the impressive development of genuine nanosized and nanostructured biomaterials and biocompatible platforms. These nanomaterials have improved biocompatibility and mostly utilize environmentally-friendly technologies for the development of novel materials for biomedical use.
Recently developed nanomaterials exhibit attractive physicochemical properties, possess versatile and tunable functionality, and have proved to be suitable and performance-enhanced candidates as bioactive nanocoatings for improved implantable and exploratory devices, nanoplatforms for specific and selective detection and imaging, nanostructures for tissue restauration and regeneration, and as nanosystems for controlled, targeted, and circumstantially triggered drug delivery.
Depending on the preparation method, the therapeutic substance (naturally derived or synthetic drug) is either physically entrapped in or covalently bound to the matrix of the pharmaceutical nanosystem. The resulting compounds may have the structure of capsules (nanoparticles or nanostructured microspheres), amphiphilic core/shell structures (micelles or liposomes), or hyperbranched macromolecules.
Within this Special Issue “Nanomaterials for Drug Delivery”, we invite members of academic and scientific communities to contribute their latest findings on nanosized and nanostructured biomaterials intended for new pharmaceutically-active formulations. We are especially looking for relevant studies and reports on organic macromolecules (natural and synthetic polymers, membranes and films, scaffolds and gels), carbonaceous materials (single and multiwalled carbon nanotubes, fullerenes, graphene and graphene oxide), oxides (nanoparticles, micro- and mesoporous materials), metal nanostructures (noble metal nanoparticles, quantum dots), and composite materials.
Dr. Eng. Valentina Grumezescu
Dr. Eng. Oana Gherasim
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Materials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- surface engineering and functionalization
- bioactive and therapeutic nanomaterials
- natural and synthetic biomaterials in drug delivery
- inorganic and organic biomaterials in drug delivery
- composite and hybrid drug delivery formulations
- pharmacologically-active formulations
- pharmacotherapy and pharmacognosy
- targeted and triggered drug delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.